期刊文献+

异基因造血干细胞移植术后移植物抗宿主病预防和治疗进展

原文传递
导出
摘要 移植物抗宿主病(GVHD)是影响异基因造血干细胞移植(Allo—HSCT)成功的主要并发症。采用目前的预防和治疗GVHD措施,对于同胞相合Allo—HSCT,急性GVHD发生率仍可高达30%~60%,因而,预防和治疗GVHD一直是移植领域所面临的重要课题。
作者 陈欢 黄晓军
出处 《国际输血及血液学杂志》 CAS 2007年第2期102-104,共3页 International Journal of Blood Transfusion and Hematology
  • 相关文献

参考文献15

  • 1陈育红,黄晓军,郭乃榄,任汉云,张耀臣,许兰平,高志勇,陆道培.异基因造血干细胞移植后急性移植物抗宿主病的发生及其危险因素的探讨[J].中华血液学杂志,2003,24(2):61-63. 被引量:45
  • 2Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after transplantatation from unrelated donor. Blood, 2000, 96: 2062-2068.
  • 3Loren AW, Luger SM, Stadtmauer EA, et al. Intensive graftversus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem ceel transplantation. Boon Marrow Transplant, 2005,35 : 921-926.
  • 4Cutler C, henry NL, Magee C, et al. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 2005, 11: 551-557.
  • 5Dipartimento EO, ospedale SM. Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis:efficacy and side effects. Boon Marrow Transplant ,2005,35:225-231.
  • 6Huang XJ, Liu DH, Liu KY, et al. Haploidentieal stem cell transplantation without in vitro T-cell depletion for the treat mentof hematological malignancies. Boon Marrow Transplantation,2006,38:291-297.
  • 7Delgado J, Thomson K, Russell Net al. Results of alemtuzumabbased reduced-intensity allogeneie transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. Blood, 2006,107(4) : 1724-30.
  • 8Barge RM, Starrenburg CW, Falkenburg JH. Long-term followup of myeloablative allogeneic stem cell transplantation using Campath "in the bag" as T-cell depletion: the Leiden experience.Bone Marrow Transplant,2006,37(12) :1129-1134.
  • 9Lazarus HM, Koe ON, Devine SM, et al. Cotransplantation of HLA-identieal sibling culture-expanded mesenehymal stem cells and hematopoietie stem cells in hematologic malignancy patients.Biol Blood Marrow Transplant, 2005,11 : 389- 398.
  • 10Przepiorka D, Kernan NA, Ippoliti C, et al. Daelizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood, 2000,95 (1)83-89.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部